GUCA2A and cancer: The strategic selection of therapeutic targets, the utilization of nanocarriers with optimal efficacy and low toxicity, and the development of gene constructs with targeted expression in cancer cells are crucial aspects of this pursuit.<h4>Methods</h4>This study employed a systems biology approach to comprehensively investigate the guanylin hormone-encoding gene (GUCA2A).